Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy

Abstract Combination therapy is rapidly becoming the cornerstone of hepatocellular carcinoma (HCC) treatment. Immune checkpoint inhibitors (ICIs) have emerged as a central strategy in systemic therapy, yet their efficacy as monotherapies remains limited. Consequently, combinatorial approaches, such...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Suoyi Dai, Yuhang Chen, Wenxun Cai, Shu Dong, Jiangang Zhao, Lianyu Chen, Chien-Shan Cheng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-09-01
coleção:	Journal of Hematology & Oncology
Assuntos:	Immune checkpoint inhibitors (ICIs) Tyrosine kinase inhibitors (TKIs) Chemotherapy Combination immunotherapy Hepatocellular carcinoma (HCC)
Acesso em linha:	https://doi.org/10.1186/s13045-025-01739-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!